2. Elger BS, Biller-Andorno N, Mauron A, Capron AM, editors. Ethical Issues in Governing Biobanks Global Perspectives. Aldershot: Ashgate Publishing; 2008.
3. National Bioethics Advisory Commission (NBAC) Research Involving Human Biological Materials: Ethical Issues and Policy Guidance. Springfield, VA: NBAC; 1999. [Accessed June 1, 2012]. Available from: http://bioethics.georgetown.edu/nbac/hbm_exec.pdf.
4. Warwick RM, Fehily D, Brubaker SA, Eastlund T, editors. Tissue and Cell Donation An Essential Guide. Chichester: Wiley-Blackwell; 2009.
5. van Diest P. No consent should be needed for using leftover body material for scientific purposes. For. BMJ. 2002;325(7365):648–651. [PubMed] 6. Savulescu J. No consent should be needed for using leftover body material for scientific purposes. Against. BMJ. 2002;325(7365):648–651. [PubMed] 7. Clayton WE. Informed consent and biobanks. J Law Med Ethics. 2005;33(1):15–21. [PubMed]
8. Price D. A Model Legal and Ethical Donation Framework. Cambridge: Cambridge University Press; 2010. Human tissue in transplantation and research.
9. Wyrsch A, dalle Carbonare V, Jansen W, et al. Umbilical cord blood from preterm human fetuses is rich in committed and primitive hematopoietic progenitors with high proliferative and self-renewal capacity. Exp Hematol. 1999;27(8):1338–1345. [PubMed]
10. Kinzfogl JM, Broxmeyer HL. Brief historical overview of hematology, cord blood, and links between the nervous and hematopoietic systems. In: Broxmeyer HE, editor. Cord Blood. Biology, Transplantation, Banking and Regulation. Bethesda, MD: AABB Press; 2011. pp. 1–6. (Advancing Transfusion and Cellular Therapies Worldwide)
11. Gluckman E, Ruggeri A, Volt F, Cunha R, Boudjedir K, Rocha V. Milestones in umbilical cord blood transplantation. Br J Haematol. 2011;154(4):441–447. [PubMed] 12. Sun J, Allison J, McLaughlin C, et al. Differences in quality between privately and publicly banked umbilical cord blood units: a pilot study of autologous cord blood infusion in children with acquired neurologic disorders. Transfusion. 2010;50(9):1980–1987. [PubMed] 13. Butler MG, Menitove JE. Umbilical cord blood banking: an update. J Assist Reprod Genet. 2011;28(8):669–676. [PMC free article] [PubMed] 14. Navarrete C, Contreras M. Cord blood banking: a historical perspective. Br J Haematol. 2009;147(2):236–245. [PubMed]
15. Committee on Establishing a National Cord Blood Stem Cell Bank Program. Umbilical cord blood banks and banking. In: Meyer EA, Hanna KE, Gebbie KM, editors. Cord Blood – Establishing a National Hematopoietic Stem Cell Bank Program. Washington, DC: The National Academy Press; 2005. pp. 75–105.
16. Sayeed A. The moral and legal status of children and parents. In: Miller G, editor. Pediatric Bioethics. Cambridge: Cambridge University Press; 2010. pp. 38–53.
17. Petrini C, Lombardini L, Pupella S, Nanni Costa A, Grazzini G. Collection, storage, and allogeneic use of cord blood: informed consent form used by the Italian Biobank Network. Biopreserv Biobanking. 2011;9(3):273–278.
18. Wall DA. Regulatory issues in cord blood banking and transplantation. Best Pract Res Clin Haematol. 2010;23(2):171–177. [PubMed] 19. Cogdell KJ. Saving the leftovers: models for banking cord blood stem cells. Univ Memphis Law Rev. 2009;39(2):229–254. [PubMed]
20. Regan DM. Cord blood banking: the development and application of cord blood banking processes, standards and regulations. In: Broxmeyer HE, editor. Cord Blood. Biology, Transplantation, Banking and Regulation. Bethesda, MD: AABB Press; 2011. pp. 633–645. (Advancing Transfusion and Cellular Therapies Worldwide)
21. Bordet S, Minh NT, Knoppers B, Isasi R. Use of umbilical cord blood for stem cell research. J Obstet Gynaecol Ca. 2010;32(1):58–61. [PubMed] 23. Petrini C, Farisco M. Informed consent for cord blood donation. A theoretical and empirical study. Blood Transfus. 2011;9(3):292–300. [PMC free article] [PubMed] 24. Annas GJ. Waste and longing – the legal status of placental-blood banking. New Engl J Med. 1999;340(19):1521–1524. [PubMed] 25. Parazzi V, Lazzari L, Rebulla P. Platelet gel from cord blood: a novel tool for tissue engineering. Platelets. 2010;21(7):549–554. [PubMed] 26. Everts PA, Knape JT, Weibrich G, et al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006;38(2):174–187. [PubMed] 27. Greppi N, Mazzucco L, Galetti G, et al. Treatment of recalcitrant ulcers with allogeneic platelet gel from pooled platelets in aged hypomobile patients. Biologicals. 2011;39(2):73–80. [PubMed] 29. United Nations Childrens’ Fund (UNICEF) Celebrating 20 Years of the Convention on the Rights of the Child. New York: UNICEF; 2009. [Accessed August 16, 2012]. The State of the World’s Children. Special Edition. Available from: http://www.unicef.org/rightsite/sowc/fullreport.php.
30. Pattinson SD. Medical Law and Ethics. Third Edition. London: Sweet and Maxwell; 2009. Property in human organs and tissue; pp. 516–525.
32. Munzer S. A Theory of Property. New York: Cambridge University Press; 1990. p. 41.
33. Haynes’ case (1614) 12 Co Rep 113 77ER.
34. Doodeward v Spence, 6 CLR 406 (1908).
35. R v Kelly & Lindsay, Q.B. 621 (1999).
36. High Court of Justice. AB and Ors v Leeds Teaching Hospital NHS Trust. Court of Appeal – Queen’s Bench Division; Mar 26, 2004. [Accessed June 1, 2012].  EWHC 644 (QB),  Lloyds Rep Med 1,  2 FLR 365,  2 WLR 358,  Fam Law 501,  QB 506, 3 FCR 324,  Lloyd’s Rep Med 1, (2004) 77 BMLR 145. Available from: http://high-court-justice.vlex.co.uk/vid/hq-0101462-52945111. 37. Hakimian R, Korn D. Ownership and use of tissue specimens for research. JAMA. 2004;292(20):2500–2505. [PubMed] 38. Petrini C. Is my blood mine? Some comments on the Convention on Human Rights and Biomedicine. Blood Transfus. 2012 In press. [PubMed] 39. Soini S, Aymé S, Matthijs G. Public and Professional Policy Committee and Patenting and Licensing Committee. Patenting and licensing in genetic testing: ethical, legal, and social issues. Eur J Hum Genet. 2008;16(Suppl 1):S10–S50. [PubMed]
40. Valverde JL. The political dimension of blood and plasma derivatives. Pharmaceutical Policy and Law. 2005;7:21–33.
41. Farrugia A, Penrod J, Bult JM. Payment, compensation and replacement – the ethics and motivation of blood and plasma donation. Vox Sang. 2010;99(3):202–211. [PubMed] 42. Council of Europe. Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Council of Europe; Oviedo, Spain: Apr 4, 1997. [Accessed June 1, 2012]. Available from: http://conventions.coe.int/Treaty/en/Treaties/html/164.htm.
43. Kits Nieuwenkamp J. The Convention on Human Rights and Biomedecine. In: Dahl Rendtorff J, Kemp P, editors. Basic Ethical Principles in European Bioethics and Biolaw. Vol. 2. Barcelona: Institut Borja de Bioèthica; 2000. pp. 325–332.
44. Council of Europe. Explanatory report. Strasbourg: Council of Europe; 1997. [Accessed June 1, 2012]. Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Available from: http://conventions.coe.int/Treaty/EN/Reports/Html/164.htm.
45. European Parliament, Council of the European Union. Directive 2004/23/EC of the European Parliament and of the Council of March 31, 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Official Journal of the European Union. 2004;L102:48–58.
46. O’Mahony B, Turner A. The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products. Vox Sang. 2012;102(2):140–143. [PubMed]
51. Guenin LM. Patents ethics, human life forms. In: Murray TH, Melhman MJ, editors. Encyclopedia of Ethical, Legal, and Policy in Biotechnology. Vol. 2. New York: John Wiley & Sons; 2000. pp. 866–880.
52. European Parliament, Council of the European Union. Directive 98/44/EC of the European Parliament and of the Council of July 6, 1998 on the legal protection of biotechnological inventions. Official Journal of the European Communities. 1998;L213:13–21.
53. Hermerén G. Patents and licensing, international controversies. In: Murray TH, Melhman MJ, editors. Encyclopedia of Ethical, Legal, and Policy in Biotechnology. Vol. 2. New York: John Wiley & Sons; 2000. pp. 817–825.
54. Wreen M. Patents. In: Chadwick Ruth F, editor. Encyclopedia of Applied Ethics. 2nd ed. Vol. 3. San Diego, CA: Academic Press; 2012. pp. 349–358.
56. Hakimian R, Korn D. Ownership and use of tissue specimens for research. JAMA. 2004;292(20):2500–2505. [PubMed]
57. Gitter DM. Ownership of human tissue: a proposal for federal recognition of human research participants’ property rights in their biological material. Wash Lee Law Rev. 2004;61(1):257–345.
58. Moore v Regents of the University of California, 793 P.2d 479 (Cal 1990).
59. Greenberg v Miami Children’s Hosp. Research Institute, Inc, 264 F Supp. 2d 1064, 1074–1076 (SD Fla 2003).
61. Gibson SF. The Washington University v. Catalona: determining ownership of genetic samples. Jurimetrics Journal. 2008;48:167–191.
62. Andrews L. Who owns your body? A patient’s perspective on Washington University v. Catalona. J Law Med Ethics. 2006;34(2):398–407. [PubMed]
64. Washington University v Catalona, 490 F.3d 667 (8th Cir 2007), cert. Denied, 128 S. Ct. 1122. 2008
65. Piccolo KM. In the wake of Catalona: an alternative model to safeguard research participants’ interests in their biological materials. Univ Pitts Law Rev. 2008;69:769–788.
66. Boo M, Welte K, Confer D. Accreditation and regulation of cord blood banking. In: Broxmeyer HE, editor. Cord Blood. Biology, Transplantation, Banking and Regulation. Bethesda, MD: AABB Press; 2011. pp. 663–672. (Advancing Transfusion and Cellular Therapies Worldwide)
68. American Medical Association (Council on Ethical and Judicial Affairs) Who Should Profit From the Economic Value of Human Tissue? An Ethical Analysis. Chicago: American Medical Association; 1990. [Accessed. June 1, 2010]. CEJA report E – A90. Available from: http://www.ama-assn.org/resources/doc/code-medical-ethics/208a.pdf. 69. WHO Expert Group. Expert Consensus statement on achieving self-sufficiency in safe blood and blood products based on voluntary non-remunerated blood donations (VNRBD) Vox Sang. 2012 Epub June 13, 2012. [PubMed]
70. Pauvert B. Le droit des éléments et produits du corps – ou les enjeux d’une réification silencieuse. [The law of bodily elements and products - or the issues of silent reification] In: Nicolas G, editor. Les Eléments et Produits du Corps Humain [The Human Body Elements and Products] Paris: Les Études Hospitalières; 2011. pp. 11–26. French.
71. Rubinstein P. Cord blood banking for clinical transplantation. Bone Marrow Transplant. 2009;44(10):635–642. [PubMed]